Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Change in Inventory (2022 - 2025)

Historic Change in Inventory for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $181000.0.

  • Orchestra BioMed Holdings' Change in Inventory rose 1036.59% to $181000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $132000.0, marking a year-over-year increase of 3750.0%. This contributed to the annual value of $28000.0 for FY2024, which is 12137.4% up from last year.
  • As of Q3 2025, Orchestra BioMed Holdings' Change in Inventory stood at $181000.0, which was up 1036.59% from $49000.0 recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Change in Inventory registered a high of $197000.0 during Q3 2022, and its lowest value of -$60000.0 during Q4 2024.
  • Moreover, its 4-year median value for Change in Inventory was -$36000.0 (2022), whereas its average is $19800.0.
  • Over the last 5 years, Orchestra BioMed Holdings' Change in Inventory had its largest YoY gain of 50000.0% in 2024, and its largest YoY loss of 85000.0% in 2024.
  • Quarter analysis of 4 years shows Orchestra BioMed Holdings' Change in Inventory stood at -$54000.0 in 2022, then surged by 114.81% to $8000.0 in 2023, then tumbled by 850.0% to -$60000.0 in 2024, then soared by 401.67% to $181000.0 in 2025.
  • Its last three reported values are $181000.0 in Q3 2025, $49000.0 for Q2 2025, and -$38000.0 during Q1 2025.